Artelo Biosciences, Inc. (ARTL) Earnings History
Net Loss12 years of earnings data (2014–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
Artelo Biosciences, Inc. (ARTL) Earnings Overview
As of June 30, 2026, Artelo Biosciences, Inc. (ARTL) reported trailing twelve-month net income of -$13M, reflecting -438.1% year-over-year growth. The company earned $-18.22 per diluted share over the past four quarters.
Looking at the long-term picture, ARTL's historical earnings data spans multiple years. The company achieved its highest annual net income of -$15,241 in fiscal 2015.
Artelo Biosciences, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including INAB (-$19M net income), OWLT (-$46M net income, -37.5% margin), AEYE (-$4M net income, -7.6% margin), ARTL has comparable earnings metrics. Compare ARTL vs INAB →
ARTL Earnings vs Peers
Earnings metrics vs comparable public companies
ARTL Historical Earnings Data (2014–2025)
12 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$13M | -31.1% | -$11M | $-5.47 | - | - |
| 2024 | -$10M | -5.8% | -$10M | $-1.02 | - | - |
| 2023 | -$9M | +7.9% | -$10M | $-1.05 | - | - |
| 2022 | -$10M | -35.6% | -$10M | $-1.16 | - | - |
| 2021 | -$7M | -59.8% | -$7M | $-1.99 | - | - |
| 2020 | -$5M | -114.3% | -$5M | $-6.28 | - | - |
| 2019 | -$2M | +7.3% | -$3M | $-5.00 | - | - |
| 2018 | -$2M | -897.7% | -$2M | $-9.17 | - | - |
| 2017 | $-234,889 | -691.1% | $-232,789 | $-1.08 | - | - |
| 2016 | $-29,690 | -94.8% | $-29,690 | $-0.16 | - | - |
| 2015 | $-15,241 | +0.2% | $-15,241 | $-0.08 | - | - |
| 2014 | $-15,269 | - | $-15,269 | $-0.20 | - | - |
Download Data
Export ARTL earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
12+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
ARTL — Frequently Asked Questions
Quick answers to the most common questions about buying ARTL stock.
What is ARTL earnings per share (EPS)?
ARTL trailing twelve-month (TTM) diluted EPS is $-18.22, reflecting -438.1% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2014 to 2025 is available in the table on this page.
What is Artelo Biosciences, Inc.'s net income?
Artelo Biosciences, Inc. (ARTL) trailing twelve-month net income is $-13M as of 2025. Earnings declined -438.1% year-over-year.
Is ARTL profitable?
ARTL is not currently profitable on a TTM basis, reporting a net loss of $-13M. Net margin is N/A. Investors should monitor for a return to profitability.
What is ARTL's earnings growth rate?
ARTL compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2014 to 2025.
What are ARTL's profit margins?
Artelo Biosciences, Inc. net profit margin is N/A, operating margin is N/A, and gross margin is N/A. Below-average margins reflect competitive or cost pressures. Return on Equity is -1625.1%.
Is ARTL growing earnings?
ARTL earnings are declining — EPS fell -438.1% year-over-year. TTM net income dropped to $-13M. This contrasts with the 5-year CAGR of N/A.
What was ARTL's best earnings year?
Artelo Biosciences, Inc.'s highest annual net income on record is $-15241.00, achieved in fiscal year 2015. Earnings history on this page spans 2014 to 2025 and includes all annual and quarterly figures.
What were ARTL's earnings last quarter?
ARTL's most recent reported quarter was Q1 2026. Net income was $-3M with diluted EPS of $-4.00. For a full breakdown of all quarters, see the quarterly earnings table on this page.